← Back to Search

Behavioral Intervention

Sleep Intervention for Childhood Acute Lymphoblastic Leukemia

N/A

Recruiting

Led By Eric Zhou, PhD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 month after the conclusion of the study period, up to 8 weeks.

Awards & highlights

Study Summary

This trial aims to improve sleep in children with cancer by studying the acceptability and feasibility of a sleep intervention program.

Who is the study for?

This trial is for children aged 4-12 with Acute Lymphoblastic Leukemia (ALL) who are in the Maintenance Phase of therapy and have finished at least two cycles. They must be able to communicate in English or Spanish along with their primary caregiver.Check my eligibility

What is being tested?

The study tests 'Sleep ALL Night', a program designed to help children with ALL sleep better. It includes an action plan tool and a psychoeducational website, aiming to facilitate discussions about sleep disorders between patients and clinicians.See study design

What are the potential side effects?

Since 'Sleep ALL Night' is a non-medical intervention focusing on education and planning, it's not expected to have physical side effects like medications do. However, individual experiences may vary.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 month after the conclusion of the study period, up to 8 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 month after the conclusion of the study period, up to 8 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month after the conclusion of the study period, up to 8 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of Intervention Measure Scale Score

Enrollment Rate of Participants

Intervention Assessment Completion Rate

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Sleep ALL NightExperimental Treatment1 Intervention

Participants and parents will complete study procedures as outlined: Baseline survey completed by participant parent(s). Introduction to Sleep ALL Night action plan. Review of psychoeducational website and completion of sleep diary. Survey completed by participant parent(s).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor

1,079 Previous Clinical Trials

340,947 Total Patients Enrolled

77 Trials studying Leukemia

10,390 Patients Enrolled for Leukemia

National Cancer Institute (NCI)NIH

13,672 Previous Clinical Trials

40,926,411 Total Patients Enrolled

1,513 Trials studying Leukemia

384,769 Patients Enrolled for Leukemia

Eric Zhou, PhDPrincipal InvestigatorDana-Farber Cancer Institute

3 Previous Clinical Trials

83 Total Patients Enrolled

Media Library

Sleep ALL Night (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05866887 — N/A

Leukemia Research Study Groups: Sleep ALL Night

Leukemia Clinical Trial 2023: Sleep ALL Night Highlights & Side Effects. Trial Name: NCT05866887 — N/A

Sleep ALL Night (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05866887 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research initiative include individuals aged sixty or above?

"This clinical trial seeks participants between the ages of 4 and 12. Clinicialtrials.gov reveals that there are 483 trials recruiting those under 18, and 1,209 trials for those over 65 years old."

Answered by AI

May I partake in this medical research?

"Potential participants of this clinical trial must have a diagnosed case of leukemia and be within the age range of 4 to 12. Approximately 30 people will be accepted for inclusion in the study."

Answered by AI

Are there any remaining vacancies in this clinical trial?

"As indicated by clinicaltrials.gov, the recruitment process for this trial has concluded and no longer requires participants. The medical study first appeared on August 1st 2023, but was last updated on May 10th 2023. Although not currently recruiting patients itself, there are 1537 other trials still seeking volunteers at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Eric Zhou, PhD 2023. "Insomnia Prevention in Children With Acute Lymphoblastic Leukemia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05866887.

All > Leukemia > All